Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility

Molecular Biology Reports

Volumn 38, Issue 7, 2011, Pages 4715-4721

  Pandey, Saumya ^a   Mittal, Balraj ^a   Srivastava, Madhu ^b   Singh, Shalini ^a   Srivastava, Kirti ^b   Lal, Punita ^a   Mittal, Rama Devi ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Cervical cancer; North India; Polymorphisms; Toll like receptor

Indexed keywords

ADENINE; CYTOSINE; GENOMIC DNA; GUANINE; THYMINE; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 9;

ADULT; ADVANCED CANCER; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; CONTROLLED STUDY; DNA EXTRACTION; ETHNICITY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; INDIA; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UTERINE CERVIX CANCER;

AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; DEMOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 9; UTERINE CERVICAL NEOPLASMS;

NICOTIANA TABACUM;

EID: 80052453174     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0607-z     Document Type: Article

References (30)

1. AP Vizcaino V Moreno FX Bosch, et al. 2000 International trends in incidence of cervical cancer: II. Squamous-cell carcinoma Int J Cancer 86 429 435 10.1002/(SICI)1097-0215(20000501)86:3<429::AID-IJC20>3.0.CO;2-D 10760834 10.1002/(SICI)1097-0215(20000501)86:3<429::AID-IJC20>3.0.CO;2-D 1:STN:280:DC%2BD3c3isFOqsQ%3D%3D
2. RA Burger BJ Monk T Kurosaki, et al. 1996 Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer J Natl Cancer Inst 88 1361 1368 10.1097/00128360-199707000-00018 8827013 10.1093/jnci/88.19. 1361 1:STN:280:DyaK28visVGmsw%3D%3D
3. JM Walboomers MV Jacobs MM Manos, et al. 1999 Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 12 19 10451482 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F 1:STN:280:DyaK1Mzot1CjsQ%3D%3D
4. NF Schlecht S Kulaga J Robitaille, et al. 2001 Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia JAMA 286 3106 3114 10.1001/jama.286.24.3106 11754676 10.1001/jama.286.24.3106 1:STN:280:DC%2BD38%2FlslGqsA%3D%3D
5. CB Woodman S Collins H Winter, et al. 2001 Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study Lancet 357 1831 1836 10.1016/S0140-6736(00)04956-4 11410191 10.1016/S0140- 6736(00)04956-4 1:STN:280:DC%2BD3MzkslOjtw%3D%3D
6. NW Schroder RR Schumann 2005 Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease Lancet Infect Dis 5 156 164 10.1016/S1473-3099(05)01308-3 15766650
7. EA Misch TR Hawn 2008 Toll-like receptor polymorphisms and susceptibility to human disease Clin Sci 114 347 360 10.1042/CS20070214 18230059 10.1042/CS20070214
8. EM El Omar MT Ng GI Hold 2008 Polymorphisms in Toll-like receptor genes and risk of cancer Oncogene 27 244 252 10.1038/sj.onc.1210912 18176606 10.1038/sj.onc.1210912 1:CAS:528:DC%2BD1cXitl2hsw%3D%3D
9. S Pandey DK Agrawal 2006 Immunobiology of Toll-like receptors: emerging trends Immunol Cell Biol 84 333 341 10.1111/j.1440-1711.2006.01444.x 16834572 10.1111/j.1440-1711.2006.01444.x 1:CAS:528:DC%2BD28XotlSmsbk%3D
10. Q Jiang H Wei Z Tian 2008 Poly I: C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway BMC Cancer 8 12 10.1186/1471-2407-8-12 18199340 10.1186/1471-2407-8-12
11. WY Kim JW Lee JJ Choi, et al. 2008 Increased expression of TLR 5 during progression of cervical neoplasia Int J Gynecol Cancer 18 300 305 17587322 10.1111/j.1525-1438.2007.01008.x 1:STN:280:DC%2BD1c7nsVahuw%3D%3D
12. UA Hasan E Bates F Takeshita, et al. 2007 TLR 9 expression and function is abolished by the cervical cancer associated human papillomavirus type 16 J Immunol 178 3186 3197 17312167 1:CAS:528:DC%2BD2sXhvFSitL4%3D
13. JW Lee JJ Choi ES Seo, et al. 2007 Increased toll-like receptor 9 expression in cervical neoplasia Mol Carcinog 46 941 947 10.1002/mc.20325 17440926 10.1002/mc.20325 1:CAS:528:DC%2BD2sXhtlWitr7K
14. S Pandey RD Mittal M Srivastava, et al. 2009 Impact of Toll-like receptors [TLR] 2 (-196 to -174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women Gynecol Oncol 114 501 505 10.1016/j.ygyno.2009.05.032 19541348 10.1016/j.ygyno.2009.05.032 1:CAS:528:DC%2BD1MXptlSrtL4%3D
15. SA Miller DD Dykes HF Polesky 1988 A simple salting-out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 1116 1215 10.1093/nar/16.3.1215 10.1093/nar/16.3.1215
16. PL Cheng HL Eng MH Chou, et al. 2007 Genetic polymorphisms of viral infection-associated Toll-like receptors in Chinese population Transl Res 150 311 318 10.1016/j.trsl.2007.03.010 17964520 10.1016/j.trsl.2007.03.010 1:CAS:528:DC%2BD2sXht1amsrbK
17. S Akira K Takeda T Kaisho 2001 Toll-like receptors: critical proteins linking innate and acquired immunity Nat Immunol 2 675 680 11477402 10.1038/90609 1:CAS:528:DC%2BD3MXlslGjtLs%3D
18. S Garantziotis JW Hollingsworth AK Zaas, et al. 2008 Effects of Toll-like receptor and Toll-like receptor genetics in human disease Annu Rev Med 59 167 183 10.1146/annurev.med.59.061206.112455 10.1146/annurev.med.59.061206.112455
19. B Beutler Z Jiang P Georgel, et al. 2006 Genetic analysis of host resistance: toll-like receptor signaling and immunity at large Annu Rev Immunol 24 353 389 10.1146/annurev.immunol.24.021605.090552 16551253 10.1146/annurev.immunol.24.021605.090552 1:CAS:528:DC%2BD28XkvFSqtL4%3D
20. JF He WH Jia Q Fan, et al. 2007 Genetic polymorphisms of TLR3 are associated with nasopharyngeal carcinoma risk in Cantonese population BMC Cancer 7 194 10.1186/1471-2407-7-194 17939877 10.1186/1471-2407-7-194
21. GE Etokebe J Knezević B Petricević, et al. 2009 Single-nucleotide polymorphisms in genes encoding Toll-like receptor-2, -3, -4, and -9 in case-control study with breast cancer Genet Test Mol Biomarkers 13 729 734 10.1089/gtmb.2009.0045 19810822 10.1089/gtmb.2009.0045 1:CAS:528: DC%2BD1MXhsFCltLrI
22. E Noguchi F Nishimura H Fukai, et al. 2004 An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population Clin Exp Allergy 34 177 183 10.1111/j.1365-2222.2004.01839. x 14987294 10.1111/j.1365-2222.2004.01839.x 1:CAS:528:DC%2BD2cXivVent74%3D
23. B Berghofer T Frommer IR Konig, et al. 2005 Common human Toll-like receptor 9 polymorphisms and haplotypes: association with atopy and functional relevance Clin Exp Allergy 35 1147 1154 10.1111/j.1365-2222.2005.02325.x 16164440 10.1111/j.1365-2222.2005.02325.x 1:STN:280:DC%2BD2Mvptl2ksg%3D%3D
24. R Lazarus WT Klimecki BA Raby, et al. 2003 Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR 9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies Genomics 81 85 91 12573264 10.1016/S0888-7543(02)00022-8 1:CAS:528:DC%2BD3sXosVynuw%3D%3D
25. V Mollaki T Georgiadis A Tassidou, et al. 2009 Polymorphisms and haplotypes in TLR 9 and MYD88 are associated with the development of Hodgkin's lymphoma: a candidate-gene association study J Hum Genet 54 655 659 19745833 10.1038/jhg.2009.90 1:CAS:528:DC%2BD1MXhsFChtrnP
26. Hold GL, Smith MG, McLean MH et al. (2006) Innate immune response gene polymorphisms and their role in H-pylori-induced gastric cancer. Gastroenterology130:A61
27. GL Hold CS Rabkin MD Gammon, et al. 2009 CD14-159C/T and TLR9-1237T/C polymorphisms are not associated with gastric cancer risk in Caucasian populations Eur J Cancer Prev 2 117 119 10.1097/CEJ.0b013e3283101292 10.1097/CEJ.0b013e3283101292
28. JM Di J Pang QP Sun, et al. 2010 Toll-like receptor 9 agonists up-regulates the expression of cyclooxygenase-2 via activation of NF-kappaB in prostate cancer cells Mol Biol Rep 37 1849 1855 19618291 10.1007/s11033-009- 9620-5 1:CAS:528:DC%2BC3cXis1WmtbY%3D
29. F Guo Y Liu Y Li, et al. 2010 Inhibition of ADP-ribosylation factor-like 6 interacting protein 1 suppresses proliferation and reduces tumor cell invasion in CaSki human cervical cancer cells Mol Biol Rep 37 3819 3825 20213509 10.1007/s11033-010-0037-y 1:CAS:528:DC%2BC3cXhtlensbbI
30. YB Zhang FL He M Fang, et al. 2009 Increased expression of Toll-like receptors 4 and 9 in human lung cancer Mol Biol Rep 36 1475 1481 18763053 10.1007/s11033-008-9338-9 1:CAS:528:DC%2BD1MXmtlOntro%3D